Stepan Q2 Sales and EBITDA Jump, But 100 Job Cuts and Soft Q3 Warning Loom
SCL sits 53% above its 52-week low of $41.82.
Summary
Stepan posted a strong Q2 rebound with sales and EBITDA gains driven by organic volume, favorable mix, higher prices, and Project Catalyst savings. This follows a brutal Q1 that included a $65.4M restructuring charge and a $41.4M net loss. The company is now cutting about 100 salaried roles and expects $75–$80M in additional restructuring charges, with $14–$18M in cash costs, mostly in H2 2026. Management warned Q3 will be somewhat lower, tempering the positive Q2 momentum. Leadership changes include a director resignation and a new Principal Accounting Officer. The restructuring signals serious cost discipline, but the soft Q3 guidance and ongoing charges keep the outlook mixed.
Updates
· SEC 10-Q — Q2 net income was $22.9M, or $1.00 per diluted share, with H1 restructuring charges of $70.5M. The company announced a workforce reduction.
At the time of this announcement, SCL was trading at $64.14 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $41.82 to $68.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.